SCHEMBL19681219

SCHEMBL19681219

CC(=O)NCCCCC(NC(C)=O)C(=O)NCCN

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.72
▸ SIRT1 Q96EB6 1/20 0.72
▸ SIRT5 Q9NXA8 2/20 0.53
▸ PAOX Q6QHF9 2/20 0.51
▸ CA1 P00915 5/20 0.50
▸ CA2 P00918 5/20 0.50
▸ FOLH1 Q04609 1/20 0.48
▸ GRIA1 P42261 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ TLR2 O60603 3/20 0.45
▸ GNAI3 P08754 1/20 0.43
▸ GNAO1 P09471 1/20 0.43
▸ GNAI1 P63096 1/20 0.43
▸ DPP7 Q9UHL4 1/20 0.43
▸ NMT2 O60551 1/20 0.42
▸ NMT1 P30419 1/20 0.42
▸ RRM1 P23921 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21309617 0.88 SIRT6 (0.69) SIRT6SIRT1SIRT5CA1CA2
SCHEMBL21167105 0.86 SIRT6 (0.62) SIRT6SIRT1SIRT5CA1CA2
SCHEMBL19546723 0.86 SIRT6 (0.69) SIRT6SIRT1SIRT5PAOXCA1
SCHEMBL13819836 0.85 SIRT6 (0.64) SIRT6SIRT1SIRT5PAOXCA1
SCHEMBL19384798 0.84 CA1 (0.63) SIRT6SIRT1CA1CA2GRIA1
Trifluoroacetic Acid SCHEMBL21293945 0.84 SIRT6 (0.60) SIRT6SIRT1SIRT5CA1CA2
SCHEMBL19401687 0.84 CA1 (0.63) SIRT6SIRT1CA1CA2GRIA1
Trifluoroacetic Acid SCHEMBL18340778 0.84 SIRT6 (0.60) SIRT6SIRT1SIRT5CA1CA2
SCHEMBL23451008 0.83 SIRT6 (0.62) SIRT6SIRT1SIRT5PAOXCA1
SCHEMBL13901989 0.83 FOLH1 (0.61) SIRT6SIRT1SIRT5FOLH1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10548952-B2 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals ADOCIA (FR) 2020-02-04 — — US disclosed
US-10383920-B2 Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals ADOCIA (FR) 2019-08-20 — — US disclosed
US-20170348396-A1 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals ADOCIA (FR) 2017-12-07 — — US disclosed
US-20170348423-A1 Injectable solution at pH 7 comprising at least one basal insulin the pl of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals ADOCIA (FR) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170348423-A1 Injectable solution at pH 7 comprising at least one basal insulin the pl of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals IAPP, IDE, INSR SIRT6 3384/4885SIRT1 4244/4885SIRT5 3476/4885
US-10383920-B2 Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals IAPP, IDE, INSR SIRT6 3177/4885SIRT1 4225/4885SIRT5 3495/4885
US-20170348396-A1 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals IAPP, F7, GIPR SIRT6 2765/4885SIRT1 3926/4885SIRT5 3475/4885
US-10548952-B2 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals IAPP, F7, GIPR SIRT6 2765/4885SIRT1 3926/4885SIRT5 3475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback